Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum

doi:10.3748/wjg.14.2905

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3521)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

327

HTML

2731

Figures (1-2)

251

Tables (1-3)

212

Sum=3521

May 14, 2008 (publication date) through Dec 20, 2024

Times Cited of This Article

Times Cited (35)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. May 14, 2008; 14(18): 2905-2911
Published online May 14, 2008. doi: 10.3748/wjg.14.2905

Full Size Figure Download Figure

Figure 2 NF-κB binding activity in mouse livers with Western blot assay. A: Normal group; B: Rosiglitazone treatment; C: Praziquantel plus rosiglitazone treatment; D: Praziquantel treatment; E: Model group.

Citation: Chen H, He YW, Liu WQ, Zhang JH. Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum. World J Gastroenterol 2008; 14(18): 2905-2911
URL: https://www.wjgnet.com/1007-9327/full/v14/i18/2905.htm
DOI: https://dx.doi.org/10.3748/wjg.14.2905